Lasa Supergenerics Quarterly Results for Trading Insights

LASA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-19 Cr
QMarch 2025
Quarterly Results

Lasa Supergenerics Quarterly Results Key Highlights

  • Revenue of ₹142 Cr in March 2025 (+0.0% vs March 2025, +36.5% vs March 2024)
  • Net Profit of ₹-19 Cr in March 2025 (+0.0% vs March 2025, +13.6% vs March 2024)
  • EBITDA of ₹-9 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of -7.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹-2.95 in March 2025 (+0.0% vs March 2025)

Lasa Supergenerics Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 107 142 104 131 137 -24.6% -
Net Profit (₹ Cr) -36 -19 -22 -39 -5 - -
EBITDA (₹ Cr) -34 -9 2 -5 16 - -
EPS (₹) -7.20 -2.95 -4.34 -7.71 -1.06 - -
Operating Margin (%) -72.0% -7.0% 2.0% -5.0% 12.0% - -

Lasa Supergenerics Share Price Trend Around Quarterly Results

Visualize Lasa Supergenerics's 1-year price movement across quarterly results — ideal for logging trades in Lasa Supergenerics share price chart using Tickjournal. All values in ₹.

Related Pages for Lasa Supergenerics

Additional stock information and data for LASA

LASA 52-week high low
Lasa Supergenerics annual reports
LASA earnings multiple
LASA value investing
Lasa Supergenerics market cap
LASA price to book ratio
LASA share price charts

Profitability Ratios

Profit Margin -13.4%
EBITDA Margin -6.3%
Operating Margin -7.0%
ROE (Annual) -22.6%

Balance Sheet Highlights

Total Assets ₹102 Cr
Total Equity ₹84 Cr
Current Assets ₹33 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹2 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹-2 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹7.78
Exchange NSE
Last Updated Mar 02, 2026

Revenue Trend (₹ Cr)

March 2023 131
March 2024 104
March 2025 142
2026 107

Net Profit Trend (₹ Cr)

March 2023 -39
March 2024 -22
March 2025 -19
2026 -36

Operating Margin Trend (%)

March 2023 -5.0%
March 2024 2.0%
March 2025 -7.0%
2026 -72.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Lasa Supergenerics quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹416,764.48 Cr 1752.5 14,875 3,125 +10.8% - 21.0% 134.8
Divis Laboratories
Sept 2025 		₹170,125.54 Cr 6403.5 2,860 689 +7.1% - 24.1% 246.6
Torrent Pharmaceuti…
Sept 2025 		₹146,658.56 Cr 4369.2 3,219 591 +11.3% - 18.4% 249.1
Cipla
Sept 2025 		₹109,178.44 Cr 1351.6 7,716 1,353 +12.0% - 17.5% 80.8
Dr Reddys Laborator…
Sept 2025 		₹107,358.50 Cr 1294.4 9,135 1,337 +1.1% - 14.6% 80.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores